Evidence map›Paper›PMID 18774901›Full record

ReviewAntioxidants & redox signaling2008

Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

John J Mieyal, Molly M Gallogly, Suparna Qanungo, Elizabeth A Sabens, Melissa D Shelton

Open access · greenAbstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 259 papers.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 524 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Redox Potential (EMolecules (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Nuclear factor kappa B expression in non-small cell lung cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Biological and Catalytic Properties of Selenoproteins.International journal of molecular sciences · 2023
    Review

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

John J MieyalDepartment of Pharmacology, Case Western Reserve University, Cleveland, Ohio 44106-4965, USA. jjm5@cwru.edu
Molly M Gallogly
Suparna Qanungo
Elizabeth A Sabens
Melissa D Shelton
Louis Stokes Cleveland VA Medical Center · USCase Western Reserve University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXINP01AG015885 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI HOPPEL, CHARLES LESLIE · 1998 to 2008
$8.1M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
PREDOCTORAL TRAINING PROGRAM IN MOLECULAR THERAPEUTICST32GM008803 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI MIEYAL, JOHN J, NIEMAN, MARVIN THOMAS · 2001 to 2023
$4.2M
Sulfhydryl Status in Aging Heart: Role of GlutaredoxinR01AG024413 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI MIEYAL, JOHN J · 2004 to 2006
$683k
Role of GRx in the regulation of calcium homeostasis in the aging heartF30AG029687 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI GALLOGLY, MOLLY M · 2007 to 2008
$85k
NEI NIH HHS 5 T32 EY07157NEI NIH HHS T32 EY007157NIA NIH HHS 1 F30 AG029687NIA NIH HHS 1 P01 AG 15885NIA NIH HHS 1 R01 AG024413NIA NIH HHS P01 AG015885NIA NIH HHS R01 AG024413NIGMS NIH HHS 2 T32 GM008803NIGMS NIH HHS T32 GM007250NIGMS NIH HHS T32 GM008803NIGMS NIH HHS T32 GM07250
6 · The paper itself

Abstract

Sulfhydryl chemistry plays a vital role in normal biology and in defense of cells against oxidants, free radicals, and electrophiles. Modification of critical cysteine residues is an important mechanism of signal transduction, and perturbation of thiol-disulfide homeostasis is an important consequence of many diseases. A prevalent form of cysteine modification is reversible formation of protein mixed disulfides (protein-SSG) with glutathione (GSH). The abundance of GSH in cells and the ready conversion of sulfenic acids and S-nitroso derivatives to S-glutathione mixed disulfides suggests that reversible S-glutathionylation may be a common feature of redox signal transduction and regulation of the activities of redox sensitive thiol-proteins. The glutaredoxin enzyme has served as a focal point and important tool for evolution of this regulatory mechanism, because it is a specific and efficient catalyst of protein-SSG deglutathionylation. However, mechanisms of control of intracellular Grx activity in response to various stimuli are not well understood, and delineation of specific mechanisms and enzyme(s) involved in formation of protein-SSG intermediates requires further attention. A large number of proteins have been identified as potentially regulated by reversible S-glutathionylation, but only a few studies have documented glutathionylation-dependent changes in activity of specific proteins in a physiological context. Oxidative stress is a hallmark of many diseases which may interrupt or divert normal redox signaling and perturb protein-thiol homeostasis. Examples involving changes in S-glutathionylation of specific proteins are discussed in the context of diabetes, cardiovascular and lung diseases, cancer, and neurodegenerative diseases.

Indexed as

Protein Processing, Post-TranslationalAnimalsCardiovascular DiseasesDiabetes MellitusGlutathioneHumansModels, BiologicalNeoplasmsOxidation-ReductionSignal TransductionGlutathione

Identifiers

PMID18774901
PMCPMC2774718
OpenAlexW2005248412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.